Rona Therapeutics raised $35 Million in Series A+ financing led by LongRiver Investments
Amount Raised
$35 Million
Round Type
Series A
ShanghaiBiotechnologyScience And EngineeringInvestors
Description
Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, completed a $35 Million Series A+ financing. LongRiver Investments led the round, with participation from investors including Zhaode Investment, BioTrack Capital, Zhongqi Capital, and Lilly Asia Ventures.
Quick answer
Rona Therapeutics raised $35 Million in a Series A round, dated July 19, 2024. Investors: Lilly Asia Ventures, Zhongqi Capital, Bio Track Capital, Zhaode Investment and Long River Investments. Rona Therapeutics is based in Shanghai, Shanghai, China.
- How much did Rona Therapeutics raise?
- Rona Therapeutics raised $35 Million in a Series A round on July 19, 2024.
- Who invested in Rona Therapeutics?
- Lilly Asia Ventures, Zhongqi Capital, Bio Track Capital, Zhaode Investment and Long River Investments are named as investors in this round.
- What does Rona Therapeutics do?
- Rona Therapeutics is a pioneering RNA therapeutics platform company dedicated to discovery and development of modular and programmable RNA medicines to deliver to patients around the world.
- Where is Rona Therapeutics based and how big is it?
- Rona Therapeutics is based in Shanghai, Shanghai, China.
- Who are the decision-makers at Rona Therapeutics?
- Fundz holds 1 contact at Rona Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Rona Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Bond Biosciences raised $2.6M (Seed) on August 22, 2024.
- Viome raised $25M on August 19, 2024.
- PrognomiQ raised $34M on August 12, 2024.
- Cardurion Pharmaceuticals raised $260M (Series B) on July 16, 2024.
- Cardurion Pharmaceuticals raised $260M (Series B) on July 16, 2024.
- Cardurion Pharmaceuticals raised $260M on July 10, 2024.
Who to call at Rona Therapeutics, and when
A new round usually means Rona Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rona Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rona Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rona Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rona Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRona Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.